Non-Invasive Characterization of Focal Liver Lesions in Liver Cirrhosis
ConditionLiver Cirrhoses
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorUniversity Hospital, Bonn
About this trial
This study aims to analyze non-invasive characterization focal liver lesions in patients with liver cirrhosis. The diagnostic accuracy and predictive value of non-invasive methods is studied.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
all patients with focal liver lesions and liver cirrhosis
Disqualifiers
no consent
under 18 years
Trial population
This study includes all adult patients in our institution with liver cirrhosis and diagnosis of focal liver lesions. Non-invasive charaterization (multiparametric ultrasound, sarcopenia assessment) and standard of care work up, treatment and follow up is applied to all patients.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Standard diagnostic procedures
Diagnostic testB-Mode ultrasound, Duplex sonography, contrast-enhanced ultrasound, elastography, CT, MRI, anthropometrics
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Diagnostic accuracy
The diagnostic accuracy of non-invasive imaging of focal liver lesions in liver cirrhosis compared to gold standard (histology, CT and/or MRI)
Time frame
1 yearSecondary outcomes
1
Predictive Value
The predictive value on mortality and treatment response of non-invasive imaging of focal liver lesions in liver cirrhosis
Time frame
up to 5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov